Erlonat medicine is used for :

• Treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC).
• Treatment of patients with locally advanced, unresectable or metastatic pancreatic cancer.

Erlonat works by slowing cancer cell growth. It binds to a certain protein (epidermal growth factor receptor-EGFR) in some tumors.

WHAT IS ERLONAT ?

ERLONAT is a targeted therapy. Erlonat is classified as a epidermal growth factor receptor (EGFR) inhibitor - protein-tyrosine kinase inhibitor. It works by helping to stop cancer cells from growing.